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Background: Aortic injury is the second most common cause of death
after blunt trauma. Thoracic endovascular aortic repair (TEVAR) has been
rapidly adopted as an alternative to the traditional open repair (OR) for
treatment of traumatic aortic injury (TAI). This paradigm shift has improved
the outcomes in these patients. The purpose of this study is to evaluate the
inpatient cost and outcomes of TEVAR compared to OR for patients with
TAI.
Methods: We analyzed prospectively collected data from the institu-
tional trauma registry between April 2002 and June 2010. These data were
supplemented with a retrospective review of hospital financial accounts.
Primary outcomes were mortality and total hospital charges. Secondary
outcomes included major complications, intensive care unit (ICU), preop-
erative, postoperative, and total hospital length of stay (LOS). Univariate
analysis was performed for comparison of outcomes and cost. Logistic
regression was used to compare the rates of complications. Wilcoxon rank
sum test was used to compare the median cost of the treatments.
Results: One hundred and six (106) consecutive patients (74 male,
mean age 36.4 years) underwent OR (n  56) and TEVAR (n  50) for
treatment of TAI. Detailed data are shown in the Table. The proportion of
patients who underwent TEVAR compared to OR increased from 0% to
100% during the study period. The TEVAR patients were significantly older
than the OR patients. There was no significant difference in the injury
severity score (ISS), mortality, stroke, paraplegia, total LOS, ICU LOS, or
median hospital cost. The incidence of uninsured patients was similar in both
groups. Due to a policy of delayed selective management, the preoperative
LOS was significantly higher for TEVAR. The rate of complications was
significantly higher for OR. For patients who underwent OR, the estimated
relative risks (95% CI) of mortality and complications were 2.23 (0.45,
11.00), and 1.79 (1.23, 2.84), respectively. Our findings were not impacted
when the comparisons were made adjusted for age.
Variable OR (N  56)
TEVAR
(N50) P value
Male N (%) 39 (69.6) 35 (70.0) 1.00
Age mean (SD) 32.16 (14.23) 41.06 (20.32) .012
ISS mean (SD) 37.96 (9.98) 36.68 (9.81) .51
Mortality N (%) 5 (8.9) 2 (4.0) .44
Stroke N (%) 0 (0.0) 1 (2.0) .48
Paraplegia N (%) 0 (0.0) 0 (0.0) 1.00
Total LOS mean (SD) 33.49 (29.08) 27.74 (23.83) .27
Pre-op LOS mean
(SD)
2.77 (6.38) 11.14 (18.51) <.0001
Post-op LOS mean
(SD)
29.73 (28.56) 16.88 (13.61) .0035
ICU LOS mean (SD) 19.80 (21.57) 16.94 (16.39) .44
Complications N (%) 32 (57.14) 16 (32.00) .012
Total charges median $85,379 $86,431 .64
Un-insured N (%) 17(30.36) 14(28.00) .68
Conclusions: Compared to OR, patients who underwent TEVAR,
despite being older, had a significant reduction in complications. Although
the observed mortality rate for OR was at least twice that of TEVAR (8.9%
vs 4.0%), the difference was not found to be statistically significant. The
median cost of TEVAR was not significantly different compared to OR.
Long-Term Secondary Procedures after Aneurysm Repair: Is EVAR
Really Worse than Open Repair
Brenton E. Quinney, Shardul B. Nagre, Marc A. Passman, Mark A. Patter-
son, SteveM. Taylor, Bart R. Combs, BruceG. Lowman,WilliamD. Jordan,
Jr, University of Alabama at Birmingham, Birmingham, Ala
Background: Since the development of endovascular repair (EVAR) of
abdominal aortic aneurysm (AAA), there remains concerns regarding its
durability, need for secondary procedures, and associated long-term mor-bidity. We compared these two approaches to evaluate their respective
long-term durability.
Methods: All patients who had undergone endovascular and open
AAA repair were identified from a prospectively maintained registry. Health
system charts, medical communication, and national death indices were
reviewed. Secondary interventions were classified as vascular (aortic graft or
remote) and nonvascular (incisional or gastrointestinal).
Results: Between July 1985 and August 2009, 1923 patients under-
went 1990 AAA repair procedures (EVAR  1064; Open  926).
Patients were followed up to 290 months (mean 27.6  35.9) and
identified with 420 surgical encounters (EVAR 224%-21.1%; Open
196%-21.2%). Most (323%-76.9%) encounters were related to vascular
disease: 173 (EVAR  128; Open  45) were related to the aortic graft;
150 (EVAR  96; Open  54) were related to nonaortic vascular
disease. The remaining 97 (23.1%) surgical encounters included inci-
sional hernias, small bowel obstruction, intrabdominal abscesses, and
wound dehiscence requiring operation. Of these 97 (EVAR - 0, Open -
97) encounters, 65 required surgical intervention, 14 required hospital-
ization, and 18 required outpatient only consultation. By survival analysis
for a period of 100 months, all-cause mortality rate was 24.5% after
EVAR and 38.8% after open repair. One-year survival was 83.6% (1.22)
and 72.4% (1.76), while 5-year survival was 63.6% (2.17) and 51.9%
(2.41) for EVAR and open repair, respectively (log-rank P value
.0001).
Conclusions: EVAR patients require more late secondary vascular
interventions than open AAA repair, but patients who undergo open repair
have more nonvascular long-term morbidity. Long-term survival is better
after EVAR compared to open repair in this selected patient group.
National Utilization and Outcome of Carotid Artery Revascularization
in Octogenarians
Caron B. Rockman, Glenn R. Jacobowitz, Neal S. Cayne, Firas F. Mussa,
Mark A. Adelman, Thomas S. Maldonado, New York University Medical
School, New York, NY
Background: The benefits of carotid endarterectomy (CEA) and ca-
rotid artery angioplasty and stenting (CAS) in octogenarians remain unclear.
Octogenarians were excluded from seminal CEA trials. CAS may have
increased complications in this patient cohort. The objective of this study
was to examine the national utilization and outcome of CEA and CAS in
octogenarians.
Methods: The Nationwide Inpatient Sample (2004-2005) was uti-
lized. ICD-9 codes were used to identify CEA and CAS cases. Outcomes
included in-hospital stroke and death. Comparisons were performed be-
tween older and younger patients. Analysis was performed among octoge-
narians to identify whether improved outcomes were noted with either
procedure.
Results: A total of 54,658 cases were analyzed; 10,826 were in
octogenarians (19.8%). Octogenarians who underwent carotid procedures
were more likely to be female (45.6% vs 41.5%, P  .001) and to die in the
hospital (1.0% vs 0.6%, P  .001) than younger patients who underwent
carotid procedures. There were no overall differences in the prevalence of
preoperative symptoms (5.4% vs 5.3%), the use of CAS as opposed to CEA
(6.0% vs 5.8%), or the overall rate of periprocedural stroke (1.1% vs 1.1%)
between octogenarians and younger patients. However, asymptomatic oc-
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asymptomatic younger patients (10.1% vs 5.7%, P  .001). In separate
analysis of octogenarians alone, it was noted that they had a significantly
higher rate of periprocedural stroke with CAS than with CEA (2.2% vs 1.1%,
P  .01). The increased rate of stroke with CAS as opposed to CEA was
noted in both asymptomatic (1.9% vs 0.9%, P .04) and symptomatic (5.2%
vs 2.3%, P  .18) octogenarians.
Conclusions: Nationally, octogenarians comprise nearly 20% of pa-
tients undergoing carotid revascularization procedures, despite concern
regarding the benefits of these procedures in older patients, particularly
when asymptomatic. In spite of additional specific concerns regarding the
complication rate of CAS in patients older than 80 years of age, asymptom-
atic octogenarians underwent CAS as opposed to CEA significantly more
frequently than younger patients. However, their periprocedural stroke rate
overall was equally low when compared to younger patients. Furthermore,
among octogenarians, the rate of periprocedural stroke was significantly
higher with CAS than with CEA, and this remained a significant finding
when asymptomatic cases were separately examined. CEA may be the
treatment of choice for properly selected octogenarians, unless compelling
reasons exist to perform CAS.
Renal Artery Stenting for Salvage of Renal Function: Preoperative
Predictors of Outcome Guide Patient Selection
J. Gregory Modrall, Carlos H. Timaran, Eric B. Rosero, Jayer Chung, Frank
A. Arko, III, R. James Valentine, G. Patrick Clagett, Clayton Trimmer,
University of Texas Southwestern Medical Center, Dallas, Tex
Background: Improved renal function after renal artery bypass surgery
has been associated with improved dialysis-free survival. Unfortunately,
renal artery bypass in patients with ischemic nephropathy carries a 4% to 7%
operative mortality rate. Renal artery stenting (RAS) offers a lower risk of
mortality, but the clinical response rates for RAS have been disappointing.
We surmise that the poor results for RAS are related to inadequate patient
selection. The purpose of this study was to identify preoperative clinical
features that predict a durable improvement in renal function with RAS.
Methods: The study cohort consisted of 43 patients with renal insuf-
ficiency (serum creatinine  1.5 mg/dL) who underwent RAS for renal
salvage. Patients were categorized as “responders” if estimated glomerular
filtration rate (eGFR) at last follow-up was improved 20% or more over
baseline. Patients with stable or worse renal function after RAS were labeled
“nonresponders.” For the purpose of calculating changes in eGFR, patients
on dialysis were represented by an eGFR of 10 mL/min/1.73 m2. Renal
volume was estimated as kidney length  width  depth/2.
Results: The median age of the cohort was 69 years (interquartile
range, IQR, 61-73 years). Median preoperative serum creatinine was 1.8
mg/dL (IQR 1.6-2.3), and median eGFR was 39 mL/min/1.73 m2 (IQR
21-46). With stenting, 11 of 43 patients (25.6%) derived a durable improve-
ment in renal function at a median follow-up of 26 months (IQR 16-36
months). Responders enjoyed a 54% improvement in renal function from
baseline, while nonresponders had a 7% decrement in renal function (P 
.0001). Responders had a higher diastolic blood pressure, higher baseline
serum creatinine, lower eGFR, and a steeper decline in renal function prior
to RAS (Table). Kidney length, width, depth, and volume were not signif-
icantly different between responders and nonresponders (Table). Logistic
regression analysis identified the rate of decline of renal function prior to
stenting as the only independent predictor of improved renal function after
RAS (odds ratio 16.7, 95% confidence interval 1.9-147.0; P  .011).
Indeed, the rate of decline in eGFR per week was more than 18-fold greater
for responders than nonresponders (3.4% vs 0.18% decline in eGFR per
week; P  .0001).
Conclusions: The current study found that a steep decline in preop-
erative renal function portends a higher likelihood of renal salvage from RAS
among patients with renal insufficiency. Incorporating this finding into
patient selection may improve outcomes for RAS.
Variables Responders Nonresponders P value
Age 71 years 68 years .62
Gender 55% male 66% male .43
Systolic blood
pressure
172 mm Hg 145 mm Hg .15
Diastolic blood
pressure
86 mm Hg 73 mm Hg .015
Serum
creatinine
2.4 mg/dL 1.7 mg/dL .025









Variables Responders Nonresponders P value
Kidney Length 9.6 cm 9.8 cm .72
Kidney Width 5.3 cm 5.4 cm .20
Kidney Depth 5.0 cm 5.1 cm .70
Kidney Volume 123 cm3 129 cm3 .53
Carotid Revascularization Outcomes Comparing Distal Filters, Flow
Reversal, and Endarterectomy
Robert Beaulieu, Luke P. Brewster, Atef Salam, Ravi Veeraswamy, Thomas
F. Dodson, Karthik Kasirajan, Emory University Hospital, Atlanta, Ga
Introduction: Contradictory outcomes exist for different methods of
carotid artery revascularization. Here we provide the comparative rates of
adverse events in patients after carotid endarterectomy (CEA), carotid artery
stenting (CAS) with distal protection (EPD), and CAS with flow reversal
technology (FRS) from a single institution by various specialists treating
carotid artery disease.
Methods: Procedural billing codes and the electronic medical records
of patients undergoing carotid artery revascularization for carotid artery
stenosis from February 2007 through March 2010 were utilized for data
collection. Primary outcome was the incidence of stroke, MI, or death after
CEA and CAS. The choice of therapy was determined by the individual
practitioner with some specialists providing both CAS and CEA (5/14).
Baseline characteristics were examined for effect on outcome. Planned
comparisons between and within groups were analyzed using 2, t tests, and
ANOVA as appropriate.
Results: There were 495 total procedures divided into carotid endar-
terectomies (226), CAS with EPD (216), and CAS with FRS (53). Preop-
erative comparisons of patient comorbidities were similar between cohorts.
Forty-two percent of these patients were symptomatic from their carotid
artery stenosis. Prior CEA was an indication for CAS over CEA (P  .001).
Significantly fewer patients undergoing CEAwere on preoperative antiplate-
let therapy (P .001) (Table I). There was no difference between groups in
the overall composite end point of death, stroke, andMI (4%, 5.1%, 0%; P
.1) or any individual major adverse event (Table II). Overall, CAS with EPD
had a statistically significant greater incidence of minor strokes when com-
pared to CEA (P  .031) which was driven by the increased stroke risk for
asymptomatic patients. Secondary endpoints occurred rarely (2%) as listed
in Table 3. There have been no reoperations or interventions in these
patients to date within this institution.
Conclusions: We have established a similar and low incidence of MI,
stroke, and death among patients undergoing CEA and CAS of whom
approximately 40%were symptomatic. The flow reversal system has provided
superior results in this series; however, its use was limited to 20% of the
carotid artery stenting procedures. Still zero adverse events in this cohort
make this an exciting technology that warrants a large-scale prospective
comparative study.
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80 years 14% 21% 19%
Symptomatic 41% 45% 32.7% .27 .43 .26
Prior CEA 12% 29% 27% .001 .001 .017
Hypertension 94% 92% 86% .13 .50 .062
Hyperlipidemia 82% 87% 69% .014 .15 .046
Renal
Disease
9% 11% 2% .084 .46 .067
Prior CVA 29% 22% 17% .087 .090 .065
Prior TIA 31% 40% 46% .067 .058 .062
Diabetes 35% 41% 36% .44 .21 .85
Prior MI 15% 13% 21% .42 .63 .31
Plavix 35% 96% 96% .001 .001 .001therapy
